MEDIGENE N (MDG1.SG)
MEDIGENE N (MDG1.SG) operates in Diversified Metals & Mining.
Market Cap & Net Worth: MEDIGENE N (MDG1.SG) (MDG1)
MEDIGENE N (MDG1.SG) (STU:MDG1) has a market capitalization of $284.48 (€277.15) as of March 19, 2026. Listed on the STU stock exchange, this Germany-based company holds position #49439 globally and #8318 in its home market, demonstrating a -18.82% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MEDIGENE N (MDG1.SG)'s stock price €0.03 by its total outstanding shares 9177 (9.18K).
MEDIGENE N (MDG1.SG) Market Cap History: 2015 to 2026
MEDIGENE N (MDG1.SG)'s market capitalization history from 2015 to 2026. Data shows change from $67.58K to $284.48 (-40.90% CAGR).
MEDIGENE N (MDG1.SG) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MEDIGENE N (MDG1.SG)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
MEDIGENE N (MDG1.SG)'s market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $67.58K | $4.89 Million | -$9.49 Million | 0.01x | N/A |
| 2017 | $224.99K | $7.80 Million | -$13.57 Million | 0.03x | N/A |
| 2018 | $131.94K | $7.58 Million | -$17.05 Million | 0.02x | N/A |
| 2019 | $71.73K | $10.51 Million | -$19.96 Million | 0.01x | N/A |
| 2020 | $63.47K | $8.00 Million | -$28.88 Million | 0.01x | N/A |
| 2021 | $50.33K | $10.46 Million | -$9.98 Million | 0.00x | N/A |
| 2022 | $36.11K | $31.25 Million | -$8.33 Million | 0.00x | N/A |
| 2023 | $27.53K | $6.03 Million | -$16.18 Million | 0.00x | N/A |
Competitor Companies of MDG1 by Market Capitalization
Companies near MEDIGENE N (MDG1.SG) in the global market cap rankings as of March 19, 2026.
Key companies related to MEDIGENE N (MDG1.SG) by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
MEDIGENE N (MDG1.SG) Historical Marketcap From 2015 to 2026
Between 2015 and today, MEDIGENE N (MDG1.SG)'s market cap moved from $67.58K to $ 284.48, with a yearly change of -40.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €284.48 | +34.82% |
| 2025 | €211.01 | -97.80% |
| 2024 | €9.59K | -65.17% |
| 2023 | €27.53K | -23.76% |
| 2022 | €36.11K | -28.24% |
| 2021 | €50.33K | -20.71% |
| 2020 | €63.47K | -11.52% |
| 2019 | €71.73K | -45.64% |
| 2018 | €131.94K | -41.36% |
| 2017 | €224.99K | +232.94% |
| 2016 | €67.58K | 0.00% |
| 2015 | €67.58K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of MEDIGENE N (MDG1.SG) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $284.48 USD |
| MoneyControl | $284.48 USD |
| MarketWatch | $284.48 USD |
| marketcap.company | $284.48 USD |
| Reuters | $284.48 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.